JTFM, the text actually mentioned settlement agreements. They market three versions of this same drug using three different delivery forms. The one I referenced was the tablet. The other two are an infusion and an inhaled powder. The combined annual sales of these products is slightly over $1B.
Perhaps Sammy is ready with the other forms through the 505b pathway.